Effect of Calcium Channel Blocking Drugs on Tumor Cell Oxygen Utilization

  • John E. Biaglow
  • Marie E. Varnes
  • Birgit Jacobson
  • Herman D. Suit
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 200)

Abstract

Oxygen tension in tumor tissue can influence the effectiveness of radiation and many chemotherapeutic agents like misonidazole, bleomycin and adriamycin, which kill tumor cells via oxygen-linked metabolic mechanisms. Therefore it is important to improve tumor oxygenation during the course of treatment with either radiation or drugs. Tumor oxygen tension can be influenced by blood flow as well as by the rate of tumor cell oxygen utilization. We have studied the factors that influence tumor cell oxygen utilization (1,2) in vitro and have previously found that pentobarbital sensitizes tumor cells to hyperbaric oxygen breathing (3). Part of the mechanism may involve either inhibition of oxygen utilization or body temperature lowering, which may also produce reoxygenation by inhibition of tumor cell oxygen utilization (4). We have found that the anaesthetic drugs chlorpromazine and stelazine inhibit cellular oxygen utilization (5). The mechanism of action of these drugs may involve alterations in voltage-dependent calcium channels. Therefore we investigated further the possibility that calcium channels were involved in cellular respiration. We have studied the currently used heart attack drugs diltiazem, nifedipine (procardia) and verapamil as well as praziquantel for their effects on tumor cell oxygen utilization in vitro. We have also determined their inhibiting capacity with tumor cells incubated in the presence of succinate and glucose, substrates known to stimulate, in the former case, and to inhibit cellular oxygen utilization in the later case.

Keywords

Dioxide Magnesium Respiration Bicarbonate Glutamine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J. E. Biaglow, M. E. Varnes, B. Jacobson and C. J. Koch, Factors influencing the oxygen consumption and radiation response of cultured mammalian cells, Adv. Expt1. Med. and Bio1 159: 347 (1983).Google Scholar
  2. 2.
    J. E. Biaglow, M. E. Varnes, B. Jacobson and H. Suit, Control of oxygen utilization in vitro and in vivo: Implications for radiotherapy of tumors, Adv. Exptl. Med. and Biol. 180: 329 (1984).Google Scholar
  3. 3.
    H. D. Suit, L. Maimonis, T.A. Rich and R.S. Sedlacek, Anaesthesia and efficacy of hyperbaric oxygen in radiation therapy, Brit. J. Radiol. 52: 244 (1979).CrossRefGoogle Scholar
  4. 4.
    J. E. Biaglow, H. D. Suit, R. E. Durand and D. E. Dosoretz, On the mechanism for enhancement of tumor radiation to hyperbaric oxygen in sodium pentobarbital anaesthetized rodents, Adv. Exptl. Med. and Biol. 180: 301 (1984).Google Scholar
  5. 5.
    M. A. Shenoy, J. E. Biaglow, M. E. Varnes and F. W. Hetzel, Inhibition of cultured human tumor cell oxygen utilization by chlorpromazine, Adv. Exptl. Med. and Biol. 159: 359 (1983).Google Scholar
  6. 6.
    : S. F. Flaim and R. Zelis (eds.), “Calcium Blockers: Mechanisms of Action and Clinical Applications”, Urban and Schwarzenberg, Baltimore, MD, (1982).Google Scholar
  7. 7.
    D. K. Norris and H. F. Bradford, On the specificity of verapamil as a calcium channel-blocker, Biochem. Pharmacol. 34: 1953 (1985).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • John E. Biaglow
    • 3
  • Marie E. Varnes
    • 3
  • Birgit Jacobson
    • 1
  • Herman D. Suit
    • 2
  1. 1.Department of Radiology, Division of Biochemical OncologyCase Western Reserve UniversityClevelandUSA
  2. 2.Edwin L. Steele Laboratory for Radiation BiologyUSA
  3. 3.Department of Radiation MedicineMassachusetts General Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations